General contact

Main switchboard
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 a.m. - 5:00 p.m. GMT+1

US switchboard

+1 862 778 21 00
Monday - Friday,
8:30 a.m. - 5:00 p.m. EST

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Investors

Investor Relations
Switzerland

Monday - Friday,
8:30 a.m. - 5:30 p.m. GMT+1
(Central European Time)

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Pharmaceutical research centers

Novartis Institutes for BioMedical Research (NIBR)

Pharmaceutical research within Novartis is conducted primarily through the Novartis Institutes for BioMedical Research (NIBR). Headquartered in Cambridge, Massachusetts, and with locations worldwide, NIBR is committed to discovering innovative medicines that treat disease and improve the lives of patients. NIBR scientists strive to improve the drug discovery process by pursuing a comprehensive, multi-disciplinary approach that integrates novel concepts across multiple disease areas.

The location of our headquarters in Cambridge – a worldwide biotechnology hub – puts NIBR close to renowned US academic institutions and in the midst of an impressive pool of scientific talent.

Diseases of the developing world

Novartis is committed to researching treatments and vaccines for diseases of the developing world through two specialized institutes:

Our efforts focus on major infectious diseases including malaria, TB, dengue and infectious diarrhea.